Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Survival curves of control subjects (bottom black line), patients with metabolic syndrome (middle black line), and diabetic patients (top black line). Normal patients: relative risk 1.00 (reference category); metabolic syndrome patients: relative risk 1.29, 95% confidence interval (CI) 1.10 to 1.51, p = 0.002; diabetic patients: relative risk 1.68, 95% CI 1.44 to 1.95, p < 0.0001. Cox proportional hazard model adjusted for age, gender, smoking habits, total cholesterol, presence of peripheral vascular disease, electrical instability, residual ischemia, left ventricular ejection fraction, n-3 polyunsaturated fatty acids, vitamin E, antiplatelet agents, angiotensin-converting enzyme inhibitors, statins at six months, and beta-blockers.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement